Home
KOL Management
26 September - 27 September 2012
KOL Management

As a pharmaceutical/healthcare professional, you know how valuable KOLs are to your organisation and how they contribute to the success of your clinical research. In today's competitive and challenging market, it is vital that relationship between the pharmaceutical/healthcare industry and KOLs are not only built but nurtured and maintained.

Identifying and engaging KOLs for your organisation is crucial to the success of your product. Entering European markets is a challenge faced by the pharmaceutical industry with ever-changing pricing structures and regulations. Working closely and adopting a culture of transparent collaboration and engagement with KOLs helps overcome some of these challenges.

SAE Media Group is proud to present KOL Knowledge Leaders focussed to keep our audience up-to-date with developments in the ever-changing KOL sphere.
 

 

FEATURED SPEAKERS

Alexander Natz

Alexander Natz

Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Eucope)
Audrey  Craven

Audrey Craven

President , European Federation of Neurological Associations (EFNA)

Alexander Natz

Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Eucope)
Alexander Natz

Audrey Craven

President , European Federation of Neurological Associations (EFNA)
Audrey  Craven

Christian Felter

Associate Director, Medical Affairs, Astellas Pharma Europe
Christian Felter

Daniel Ghinn

Director of Digital Engagement, Healthcare, Creation Interactive
Daniel Ghinn

David Gillen

Medical Director , Celgene Europe Limited
David Gillen

Johanna Jarvis

Managing Director , Jarvis Consulting
Johanna Jarvis

Keith Allan

Director of Global Advocacy, Novartis International AG
Keith Allan

Mario Monella

Director of Medical Affairs, Astellas Pharma Europe Ltd
Mario Monella

Mario Ottiglio

Associate Director Public Affairs & Global Health Policy , IFPMA
Mario Ottiglio

Michal Konstacky

Aerocrine, Head of Medical Affairs
Michal Konstacky

Miriam George

CEO, PDC Healthcare
Miriam  George

Neil Ranasinghe

Medical Sciences Manager, BMS
Neil Ranasinghe

Sanjita Panchal

Medical Science Liaison, Merck Sharp & Dohme Ltd
Sanjita  Panchal

Shaul Brazil

Barrister, BCL Burton Copeland
Shaul Brazil

Susanna Palkonen

Executive Officer, EFA
Susanna Palkonen

Tim Curry

Assistant Head of Nursing , Royal College Of Nursing Of The United Kingdom
Tim Curry

Wisia Wedzicha

Professor of Respiratory Medicine, University College London
Wisia Wedzicha

Conference agenda

clock

8:30

Registration & Coffee

clock

9:00

Chairman's Opening Remarks

Wisia Wedzicha

Wisia Wedzicha, Professor of Respiratory Medicine, University College London

David Gillen

David Gillen, Medical Director , Celgene Europe Limited

clock

9:10

KOL for pharmaceuticals: defining the landscape

Wisia Wedzicha

Wisia Wedzicha, Professor of Respiratory Medicine, University College London

  • What is the nature of the role of a KOL in the development process?
  • How will we define and recognise a KOL?
  • Objective-driven approach to initiate partnership with the pharmaceutical industry
  • Ensuring the right KOL is identified for the right project
  • clock

    9:50

    Ensuring regulatory compliance with key external expert data

    Mario Monella

    Mario Monella, Director of Medical Affairs, Astellas Pharma Europe Ltd

  • Industry trends in KEE database management
  • Common issues and uncertainties related to privacy
  • Structure and strategies for ensuring global compliance
  • clock

    10:30

    Morning Coffee

    clock

    10:50

    Key elements of a Stakeholder Relations

    Johanna Jarvis

    Johanna Jarvis, Managing Director , Jarvis Consulting

  • Stepwise approach to stakeholder relations business planning
  • Standardising stakeholder engagement planning
  • clock

    11:30

    The evolving role of the KOL in the pharmaceutical industry

    Christian Felter

    Christian Felter, Associate Director, Medical Affairs, Astellas Pharma Europe

  • Understanding the role of the KOL for your organisation
  • How does the role differ through the late research and early development phase
  • In what direction is the area evolving?
  • Collating and interpreting feedback from criticisms; learning from past mistakes
  • clock

    12:10

    Global health agenda: overcoming the challenges

    Mario Ottiglio

    Mario Ottiglio, Associate Director Public Affairs & Global Health Policy , IFPMA

  • Understanding what the top priorities are for the global health agenda
  • Identifying what our industry is expected to deliver
  • Overcoming challenges
  • Looking to the future
  • clock

    12:50

    Networking Lunch

    clock

    14:00

    The internet, social media and mobile

    Daniel Ghinn

    Daniel Ghinn, Director of Digital Engagement, Healthcare, Creation Interactive

  • How emerging channels are changing healthcare engagement
  • Focus on how pharma's stakeholder communicate
  • Influencing other KOLs using emerging channels
  • What does this mean for the pharma industry?
  • clock

    14:40

    Evolution of MSL role in different European markets

    David Gillen

    David Gillen, Medical Director , Celgene Europe Limited

  • Assessing the changing roles of MSLs
  • Dealing with patient expirations and mergers and acquisitions in the industry
  • Getting top-level management buy-in for MSLs
  • Building depper relationships in the European market
  • clock

    15:20

    Afternoon Tea

    clock

    15:40

    The implications of the Bribery Act 2010 for pharmaceutical/healthcare companies’ relationships with KOLs

    Shaul Brazil

    Shaul Brazil , Barrister, BCL Burton Copeland

  • Overview of the main aspects of the Bribery Act
  • The relevance of the Bribery Act to KOL relationships
  • The practical implications for KOL relationships
  • Effective procedures for ensuring compliance
  • clock

    16:20

    Stakeholder Relations: What is it? What is the value?

  • Stakeholder Relations Environmental changes and challenges
  • Standardising Stakeholder Relations business and engagement planning
  • Effective interaction with key stakeholder groups
  • Joint presentation with a key Stakeholder on effective interaction
  • Johanna Jarvis

    Johanna Jarvis, Managing Director , Jarvis Consulting

    Tim Curry

    Tim Curry, Assistant Head of Nursing , Royal College Of Nursing Of The United Kingdom

    clock

    17:00

    Chairman’s Closing Remarks and Close of Day One

    clock

    8:30

    Registration & Coffee

    clock

    9:00

    Chairman's Opening Remarks

    Keith Allan

    Keith Allan, Director of Global Advocacy, Novartis International AG

    clock

    9:10

    Adopting a culture of transparent engagement and collaborations with pharmaceuticals

    Neil Ranasinghe

    Neil Ranasinghe, Medical Sciences Manager, BMS

  • Why transparency regarding KOL/pharma  interactions benefits everyone involved
  • What can KOLs offer healthcare professionals
  • What can healthcare professionals offer the industry when interacting with MSLs
  • How an MSL/KOL guidance can help all involved
  • clock

    9:50

    Assessing the impact of current legislation on relationships between pharmaceutical companies and KOLs’

    Audrey  Craven

    Audrey Craven, President , European Federation of Neurological Associations (EFNA)

     

  • Partnerships for progress
  • Sharing best practice
  • Building capacity
  • Influencing policy makers
  • clock

    10:30

    Morning Coffee

    clock

    10:50

    Measuring the success of your KOL program

    Sanjita  Panchal

    Sanjita Panchal, Medical Science Liaison, Merck Sharp & Dohme Ltd

  • Measuring internal success: identifying and engaging with your KOL
  • Demonstrating the success to management
  • Predicting future success
  • clock

    11:30

    Understanding German legislation and increased regulatory enforcement

    Alexander Natz

    Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Eucope)

  • Familiarising yourself with European and German legislation
  • The need for improved transparent information and the new information to patients proposal of the European Commission
  • Codes of conduct, patient and KOL involvement
  • Pharmacovigilance and restrictions of advertisement laws
  • Creating a compliance team within your organisation to suit the European markets
  • clock

    12:10

    Networking Lunch

    clock

    13:30

    Getting the relationship right: Interaction between KOL and the pharmaceutical industry

    Keith Allan

    Keith Allan, Director of Global Advocacy, Novartis International AG

  • Reviewing the state of the relationship between pharma and the medical research community
  • Evolving new approaches to working together for the benefit of medicine
  • Ensuring a flexible and customised program that fits the unique needs of each key opinion leader
  • Identifying where the challenge currently lies in the relationship and rectifying this through effective management

     

  • clock

    14:10

    Engaging with Patient Opinion Leaders (POLs)

    Susanna Palkonen

    Susanna Palkonen, Executive Officer, EFA

  • New legislation and how this will effect KOL relations
  • Will Patient Opinion Leaders (POLs) replace KOLs
  • How to get these groups on board
  • How do patient organisations feel about engaging
  • clock

    15:20

    The changing profiles of KOL

    Miriam  George

    Miriam George, CEO, PDC Healthcare

  • New environment, new opportunities
  • Providing more than just a drug
  • Demonstrating value
  • clock

    16:00

    Afternoon Tea

    clock

    16:30

    Chairman’s Closing Remarks and Close of Day Two


    Associate Director, Medical Affairs
    Astellas Pharma Europe
    Associate Director Public Affairs & Global Health Policy
    IFPMA
    Barrister
    BCL Burton Copeland
    CEO
    PDC Healthcare
    Managing Director
    Jarvis Consulting
    Medical Director
    Celgene Europe Limited
    Aerocrine
    Head of Medical Affairs
    President
    European Federation of Neurological Associations (EFNA)
    Secretary General
    European Confederation of Pharmaceutical Entrepreneurs (Eucope)
    Director of Global Advocacy
    Novartis International AG
    Assistant Head of Nursing
    Royal College Of Nursing Of The United Kingdom
    Executive Officer
    EFA
    Director of Digital Engagement, Healthcare
    Creation Interactive
    Medical Sciences Manager
    BMS
    Medical Science Liaison
    Merck Sharp & Dohme Ltd
    Professor of Respiratory Medicine
    University College London
    Director of Medical Affairs
    Astellas Pharma Europe Ltd

    Copthorne Tara Hotel

    Scarsdale Place
    Kensington
    London W8 5SR
    United Kingdom

    Copthorne Tara Hotel

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

     

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download

    Title


    Description

    Download

    Title


    Description


    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    Group Booking

    Please complete the below form and a member of SAE Media Group’s booking team will be in contact within 24 hours

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data.privacy@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

    Fill in your details to download the brochure

    By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.